Vertex Pharmaceuticals, Inc.
(NASDAQ : VRTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.30%171.891.3%$501.59m
BIIBBiogen Inc.
1.59%236.631.3%$486.91m
CELGCelgene Corporation
0.17%96.411.3%$469.40m
GILDGilead Sciences, Inc.
0.17%66.630.9%$452.90m
ILMNIllumina, Inc.
2.16%313.083.5%$316.47m
REGNRegeneron Pharmaceuticals, Inc.
3.05%319.392.6%$293.17m
AAgilent Technologies, Inc.
-0.15%68.221.6%$199.66m
VRTXVertex Pharmaceuticals Incorporated
2.92%174.061.9%$182.77m
EXASExact Sciences Corporation
-1.36%95.6325.3%$168.50m
ALXNAlexion Pharmaceuticals, Inc.
-0.33%128.372.0%$150.94m
BMRNBioMarin Pharmaceutical Inc.
0.66%88.054.3%$118.48m
SRPTSarepta Therapeutics, Inc.
0.91%122.2914.7%$116.53m
INCYIncyte Corporation
0.94%79.422.5%$107.75m
IONSIonis Pharmaceuticals, Inc.
-0.95%68.588.2%$98.40m
ALNYAlnylam Pharmaceuticals, Inc
1.00%68.559.2%$96.57m

Company Profile

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.